Please refer to ClinicalTrials.gov : NCT02864953.
Phase 3
Terminated
- Conditions
- arge Hemispheric Infarction
- Registration Number
- JPRN-jRCT2080224029
- Lead Sponsor
- Biogen Japan Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- terminated
- Sex
- All
- Target Recruitment
- 768
Inclusion Criteria
Please refer to ClinicalTrials.gov : NCT02864953.
Exclusion Criteria
Please refer to ClinicalTrials.gov : NCT02864953.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method